🇺🇸 FDA

Intelligence Platform

Patents

Browse 158 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9856264

Isoquinolinesulfonyl derivative as RHO kinase inhibitor

Medshine Discovery Inc. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856260

Compounds useful for inhibiting metastasis from cancer and methods using same

Alliance Discovery, Inc. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9493626

Dispersions comprising discrete carbon nanotube fibers

MOLECULAR REBAR DESIGN, LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9365626

Simukunin

The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9341626

Selective cytopheresis devices and related methods thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9102626

Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9040626

Nanofibers and morphology shifting micelles

The Regents of the University of California · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993626

Methods of treatment using sterculic acid

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962642

5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962637

Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962663

Small molecule inhibitors of the pleckstrin homology domain and methods for using same

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962685

Creatine oral supplementation using creatine hydrochloride salt

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962677

Methods of restoring cognitive ability using non-peptidic compounds

Acumen Pharmaceuticals, Inc. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962643

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962653

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962631

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8852626

Controlled-release CNS modulating compositions and methods for the treatment of otic disor

The Regents of the University of California · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8790626

Method for treating hair growth disorders, such as female pattern alopecia, and compositio

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8716265

4-quinolinemethanols as anti-malarial agents

Jenrin Discovery, LLC · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658626

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8586626

Metabolites of wortmannin analogs and methods of using the same

Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8530626

Methods to produce keratin elastomer

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8476263

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8466267

Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene

Sangamo Biosciences, Inc. · Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted